"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 4 | 4 |
| 2000 | 4 | 2 | 6 |
| 2001 | 3 | 3 | 6 |
| 2002 | 8 | 2 | 10 |
| 2003 | 8 | 7 | 15 |
| 2004 | 8 | 4 | 12 |
| 2005 | 14 | 6 | 20 |
| 2006 | 5 | 9 | 14 |
| 2007 | 11 | 8 | 19 |
| 2008 | 16 | 6 | 22 |
| 2009 | 16 | 5 | 21 |
| 2010 | 13 | 10 | 23 |
| 2011 | 18 | 9 | 27 |
| 2012 | 18 | 9 | 27 |
| 2013 | 21 | 8 | 29 |
| 2014 | 25 | 5 | 30 |
| 2015 | 23 | 5 | 28 |
| 2016 | 20 | 6 | 26 |
| 2017 | 21 | 6 | 27 |
| 2018 | 26 | 6 | 32 |
| 2019 | 30 | 5 | 35 |
| 2020 | 30 | 5 | 35 |
| 2021 | 29 | 10 | 39 |
| 2022 | 27 | 0 | 27 |
| 2023 | 35 | 2 | 37 |
| 2024 | 20 | 9 | 29 |
| 2025 | 27 | 5 | 32 |
| 2026 | 16 | 2 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Hypoglossal Nerve Stimulation and the Incidence of Cardiovascular Disease. JAMA Otolaryngol Head Neck Surg. 2026 Sep 01; 152(9):858-867.
-
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials. Eur Heart J. 2026 Jul 07; 47(26):3404-3414.
-
Trends in cardiometabolic disease and health-related quality of life in the United States, 2001-2022. Qual Life Res. 2026 Jun 15; 35(8).
-
Association between migration and cardiovascular health in Mexicans: a binational analysis using the Hispanic Community Health Study (HCHS/SOL) and Mexican Family Life Survey (MxFLS). J Epidemiol Community Health. 2026 Jun 10; 80(7):503-511.
-
Role of Physical Activity in Obesity Treatment and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2026 Jul 07; 154(1):e1-e16.
-
Life's Essential 8 in Pregnancy and Time to Incident Cardiometabolic Disease Over 7 Years Follow-Up. JAMA Netw Open. 2026 06 01; 9(6):e2619910.
-
Comparative effectiveness of sulfonylureas on kidney outcomes in adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulation. BMJ Open Diabetes Res Care. 2026 May 21; 14(3).
-
A Large, Diverse, Urban Cardiovascular Health e-Cohort in Childhood and Adolescence: Protocol for the Young Hearts Study. JMIR Res Protoc. 2026 05 21; 15:e82619.
-
Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial. J Am Heart Assoc. 2026 05 19; 15(10):e046238.
-
Social Determinants of Cardiovascular Disease Risk Factors Among Black Ethnic Groups: Findings From the 2013 to 2018 National Health Interview Survey. J Am Heart Assoc. 2026 04 21; 15(8):e047268.